Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
04/05/2026 02:03
May 4 (Reuters) - Arovella Therapeutics Ltd ALA.AX: BOARD REFRESH AND CEO RESIGNATION DR MICHAEL BAKER RESIGNS AS CEO AND MANAGING DIRECTOR APPOINTS DAVID WILLIAMS AS CHAIRMAN OF THE BOARD Further company coverage: ALA.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arovella Therapeutics
See all newsBrief: Arovella Therapeutics Appoints Acting CEO
Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
Brief: Arovella Therapeutics Says Elizabeth Stoner Will Be Retiring As Interim Chair
Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
Brief: Arovella Therapeutics Appoints Lachie Mallia As CFO